Phase II Trial of 10-Day ASTX727 (Decitabine/Cedazuridine) with Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia-MedSci.cn - 梅斯（MedSci）

Phase II Trial of 10-Day ASTX727 (Decitabine/Cedazuridine) with Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia

Maiti, A; DiNardo, CD; Ohanian, M; Daver, N; Borthakur, G; Chien, KS; Issa, GC; Takahashi, K; Masarova, L; Valero, YA; Jabbour, E; Wierda, WG; Short, NJ; MacFarland, M; Pike, A; Kadia, TM; Ravandi, F; Kantarjian, HM; Garcia-Manero, G; Konopleva, MY

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务